基于MRI影像组学预测PI-RADS 3病变中临床显著性前列腺癌:方法学变异与性能的文献综述
本综述检索2017年1月至2024年9月PubMed、EMBASE和SCOPUS数据库,纳入14项研究,评估基于MRI的影像组学模型预测PI-RADS 3病变中临床显著性前列腺癌的性能与方法学质量。模型汇总AUC为0.823(95%CI 0.72, 0.92),平均影像组学质量评分(RQS)为15/36(范围13-19),作者认为现有研究需通过广泛验证和开放数据发表来提高方法学质量。
要点
- PI-RADS 3病变中,MRI影像组学模型预测临床显著性前列腺癌的汇总AUC为0.823(95%CI 0.72, 0.92)。
- 纳入研究的平均RQS仅15/36(范围13-19),方法学质量有待提高。
- 14项研究中13项采用手动分割,最常用的特征筛选方法为LASSO。
核心结论
- 基于MRI的影像组学模型在预测PI-RADS 3病变中的临床显著性前列腺癌方面具有潜力,但以RQS为指南,现有和未来研究明确需要通过关注广泛验证和开放数据发表以提高方法学质量。
研究设计与样本
- 系统文献综述,检索PubMed、EMBASE和SCOPUS数据库2017年1月至2024年9月发表的文献,最终纳入14项研究。
诊断标准与关键数值
- 模型预测临床显著性前列腺癌的汇总AUC为0.823(95%CI 0.72, 0.92);平均RQS评分为15/36(范围13-19)。
局限性
- 平均RQS评分仅为15/36(范围13-19),现有研究方法学质量有待提高。
- 作者指出明确需要通过广泛验证和开放数据发表来提高现有和未来研究的方法学质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the current state of MRI-based radiomics for predicting clinically significant prostate cancer (csPCa) in PI-RADS 3 lesions and assess the quality of these radiomic studies via a systematic review of the published literature.
METHODS: We conducted a literature search in PubMed, EMBASE, and SCOPUS databases from January 2017 to September 2024, using search terms containing variations of PI-RADS-3 and radiomics in abstract and titles. We collected details from the radiomic workflow for each study, including statistical performance of the radiomics models (area under the curve (AUC)). We calculated the pooled AUC across the studies and a radiomics quality score (RQS) to evaluate the quality of radiomics methodology.
RESULTS: Of 52 articles retrieved, 14 met the selection criteria. Of these, 12 studies employed 3T MRI scanners, 8 studies T2WI, DWI, ADC images for feature extraction, and 13 studies performed manual segmentation. All but two studies used the PyRadiomics platform as their feature extraction tool. The most commonly used radiomic selection methods were Least Absolute Shrinkage and Selection Operator (LASSO). The total number of features extracted ranged between 107 and 2553. The median number of radiomics features selected for use in models was 10. Nine studies (9/14) explored clinical variables in their radiomics models, with the most common being age and PSA. For building the final model, Logistic Regression, and Univariate and Multivariate modeling methods were featured across eight studies (8/14). Overall performance of the models by pooled AUC was 0.823 (95% CI, 0.72, 0.92). The mean RQS score was 15/36 (range 13-19).
CONCLUSION: MRI-based radiomic models have potential in predicting csPCa in PI-RADS-3 lesions. However, using RQS as a guide, we determined there is a clear need to improve the methodological quality of existing and future studies by focusing on extensive validation and open publishing of data for reproducibility.
引用
- Serrano A, Louviere C, Singh A, et al. Predicting clinically significant prostate cancer in PI-RADS 3 lesions using MRI-based radiomics: a literature review of methodological variations and performance. Abdom Radiol (NY). 2025. PMID: 40172658. doi:10.1007/s00261-025-04914-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。